(www.affinergy.com), a developer of site-specific biological systems, has formed a multi-year strategic alliance with the Musculoskeletal Transplant Foundation (MTF), a not-for-profit consortium of academic medical institutions. MTF will utilize Affinergy's peptide linkers to enhance a variety of products. Affinergy will be working exclusively with MTF in the field of human allograft on a worldwide basis.
The Musculoskeletal Transplant Foundation is the world's largest tissue organization dedicated to providing quality tissue through a commitment to excellence in education, research, recovery and care for recipients, donors and their families.
Affinergy is a CED member.